Literature DB >> 9598176

No circadian variation of dihydropyrimidine dehydrogenase, uridine phosphorylase, beta-alanine, and 5-fluorouracil during continuous infusion of 5-fluorouracil.

A B Van Kuilenburg1, R L Poorter, G J Peters, A H Van Gennip, H Van Lenthe, A E Stroomer, K Smid, P Noordhuis, P J Bakker, C H Veenhof.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9598176     DOI： 10.1007/978-1-4615-5381-6_156

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers.

Authors:  Bart A W Jacobs; Maarten J Deenen; Dick Pluim; J G Coen van Hasselt; Martin D Krähenbühl; Robin M J M van Geel; Niels de Vries; Hilde Rosing; Didier Meulendijks; Artur M Burylo; Annemieke Cats; Jos H Beijnen; Alwin D R Huitema; Jan H M Schellens
Journal:  Br J Clin Pharmacol       Date:  2016-06-03       Impact factor: 4.335

Review 2.  How may anticancer chemotherapy with fluorouracil be individualised?

Authors:  Su-arpa Ploylearmsaeng; Uwe Fuhr; Alexander Jetter
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Profound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients.

Authors:  A B Van Kuilenburg; H van Lenthe; M J Blom; E P Mul; A H Van Gennip
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

4.  Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion.

Authors:  Gini F Fleming; Philip Schumm; Greg Friberg; Mark J Ratain; Uchenna O Njiaju; Richard L Schilsky
Journal:  BMC Cancer       Date:  2015-02-18       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.